A Systems View Across Time and Space
Table 5 Descriptive statistics
From: On valuing biopharmaceutical product pipelines: an effectuation model and evidence
Number | Minimum | Maximum | Mean | Std. deviation | |
|---|---|---|---|---|---|
RnDExpense | 216 | 0.00 | 11.11 | 2.20 | 2.30 |
RnDpercent | 216 | 0.00 | 12.50 | 0.28 | 0.89 |
ValuePipeline | 179 | −0.23 | 1.00 | 0.72 | 0.28 |
Sales | 216 | 0.00 | 67.22 | 14.99 | 16.21 |
Income | 216 | −2.07 | 19.33 | 2.68 | 3.28 |
MarketValue | 231 | 2.29 | 911.99 | 107.45 | 118.24 |
PriceEarnings | 201 | −27.49 | 4185.76 | 104.63 | 338.94 |
Valid N (listwise) | 179 |